LHRH analogues in early breast cancer.
A steering group has devised a protocol to compare relapse-free survival rates between women under 50 with stage II cancer, given CMF or Zoladex as adjuvant therapy. The design of the trial is discussed.
Jonat
W
W
University Hospital, Hamburg, FRG.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002064:Buserelin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D017273:Goserelin; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged
D017273:Goserelin; D003520:Cyclophosphamide; D002064:Buserelin; D005472:Fluorouracil; D008727:Methotrexate